Month: April 2017

• April 25, 2017
• Focal Treatment & Laser Ablation

The Sperling Prostate Center Joins Focal MRgFUS Clinical Trial

The Sperling Prostate Center joins a prestigious group of academic and community medical centers participating in a Phase Three clinical trial of a new prostate cancer focal treatment. Dr. Sperling is the Principal Investigator at our Boca Raton, FL study site. The treatment under investigation is MRI-guided Focused Ultrasound (MRgFUS), a noninvasive technology for the keep reading

• April 9, 2017
• Active Surveillance

Why Choose the Sperling Prostate Center for Active Surveillance?

With Active Surveillance on the rise, one would think that doctors who support AS for their prostate cancer patients have similar commitment and protocols. A new study (Sep. 2016) in the British Journal of Urology International (BJUI) spells out 8 areas of qualitative differences among AS doctors: physician comfort with active surveillance protocol selection beliefs keep reading